Law & Policy

·

Policy

DEA Says Right to Try Law Doesn't Cover Psilocybin

DEA Says Right to Try Law Doesn't Cover Psilocybin

Psilocybin mushrooms

What they found

The DEA told a court that the federal Right to Try law for terminally ill patients does not override the Controlled Substances Act for psilocybin.

The DEA told a court that the federal Right to Try law for terminally ill patients does not override the Controlled Substances Act for psilocybin.

How solid is it?

n/a

n/a

Not a study

Not a study

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin

psilocybin

Published in

Psychedelic News Wire

Psychedelic News Wire

Covered in Shroom Scan

Section

Psychedelic spotlight

Psychedelic spotlight

As it ran in Shroom Scan

The Right to Try

The Right to Try

The U.S. DEA claims that a law allowing patients with terminal illnesses to try investigative medications does not overrule the Controlled Substances Act regarding psilocybin.

The U.S. DEA claims that a law allowing patients with terminal illnesses to try investigative medications does not overrule the Controlled Substances Act regarding psilocybin.

Mushroom bonsai + the "right to try" debate 🍄

Read the original study ↗

Get Shroom Scan

Next study

NIH Funds Research on Psychedelics for Chronic Pain in Older Adults ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →